The streetlight effect-is there light at the end of the tunnel?

Diabetes

Volumn 64, Issue 4, 2015, Pages 1105-1107

  Lernmark, Åke ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUCOSE; GLUTAMATE DECARBOXYLASE 65; HEMOGLOBIN A1C; INSULIN; PANCREAS ISLET CELL ANTIBODY; UNCLASSIFIED DRUG; ZINC TRANSPORTER; ZINC TRANSPORTER 8;

AUTOIMMUNE DISEASE; DIABETIC PATIENT; FOLLOW UP; GENETICS; HUMAN; HYPERGLYCEMIA; HYPERPHAGIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; INSULITIS; NOTE; PATHOGENESIS; POLYDIPSIA; POLYURIA; PRIORITY JOURNAL; RISK FACTOR; ANIMAL; DIABETES MELLITUS, TYPE 1; PATHOLOGY; RESEARCH;

ANIMALS; DIABETES MELLITUS, TYPE 1; HUMANS; RESEARCH;

EID: 84929991568     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db15-0011     Document Type: Note

References (16)

1. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006;355: 1318-1330
2. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000;342: 381-389
3. Lind M, Svensson AM, Kosiborod M, et al. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med 2014;371: 1972-1982
4. Battaglia M, Atkinson MA. The streetlight effect in type 1 diabetes. Diabetes 2015;64: 1081-1090
5. Huxley TH. Biogenesis and abiogenesis. In Collected Essays: Discourses, Biological and Geological. Cambridge University Press, Cambridge, U.K., 1870, p. 229-271
6. Yoon JW, Austin M, Onodera T, Notkins AL. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 1979;300: 1173-1179
7. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965;14: 619-633
8. Nerup J, Platz P, Andersen OO, et al. HL-A antigens and diabetes mellitus. Lancet 1974;2: 864-866
9. Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974;2: 1279-1283
10. Lendrum R, Walker G, Gamble DR. Islet-cell antibodies in juvenile diabetes mellitus of recent onset. Lancet 1975;1: 880-882
11. Gorsuch AN, Spencer KM, Lister J, et al. Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus. Lancet 1981;2: 1363-1365
12. Ilonen J, Hammais A, Laine AP, et al. Patterns of β-cell autoantibody appearance and genetic associations during the first years of life. Diabetes 2013; 62: 3636-3640
13. Ziegler AG, Rewers M, Simell O, et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 2013;309: 2473-2479
14. Akolkar B; Teddy Study Group. The six-year incidence of diabetes associated autoantibodies in the genetically at-risk: The TEDDY Study. Presented at the Immunology of Diabetes Society 13th Congress, 7-11 December 2013, at the Mantra Resort, Lorne, Australia
15. Concannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes. N Engl J Med 2009;360: 1646-1654
16. Törn C, Hadley D, Lee H-S, et al.; the TEDDY Study Group. Role of type 1 diabetes associated SNPs on risk of autoantibody positivity in the TEDDY Study. Diabetes. 24 November 2014 [Epub ahead of print]. DOI: 10.2337/ db14-1497